Mobile Menu

Pharmaceutical Preparations Manufacturing in Ireland - Market Research Report (2014-2029)

Harry Dee Harry Dee London, United Kingdom Last Updated: November 2024 SIC C21.200IE

Revenue

€66.2bn

2024

€70.8bn

Past 5-Year Growth

Profit

€XX.Xbn

Employees

19,130

Businesses

124

Wages

€X.Xbn

Pharmaceutical Preparations Manufacturing in Ireland industry analysis

Pharmaceuticals are a core segment of Ireland's economy, accounting for a leading share of national exports. Low corporate tax rates and generous research and development tax credits offered by the Irish state make the country a highly appealing location for multinational pharmaceutical manufacturers to base their European operations. Consequently, nine of the 10 largest pharmaceutical companies in the world have a presence in the country. Ireland is also the largest net exporter of pharmaceuticals in the EU, accounting for over 42.4% of all exports from the country, according to CSO data.

Trends and Insights

  • Rising prevalence of chronic illnesses. As people get older, they are more likely to develop chronic illnesses and require medical intervention. The rising prevalence of diabetes and obesity has boosted pharmaceutical manufacturing activity.
  • Demand for therapeutic and prophylactic medication is growing. This segment's share of revenue has remained fairly stable over the past few years, as the effects of growing demand from Ireland's ageing population are mitigated by increased penetration of low-cost generic products.
  • Dublin accounts for a high number of pharmaceutical manufacturing establishments. A large number of pharmaceutical companies have their headquarters in the capital, where there is greater access to a graduate workforce.
  • For non-patented products, manufacturers compete heavily on price. However, some manufacturers can use reputational advantages due to the importance consumers place on product quality.

Access hundreds of analysis and data

  • Market estimates from 2014-2029
  • Critical performance data and rankings
  • Detailed analysis of competitive forces and the external environment
  • PDF report or online database with Word, Excel and PowerPoint export options
  • 100% money back guarantee

Industry Statistics and Trends

Market size and recent performance (2014-2029)

Industry revenue has grown at a CAGR of 3.8 % over the past five years, to reach an estimated €66.2bn in 2024.

Trends and Insights

Ireland's ageing population has aided medicine sales

  • As people age, they are more likely to develop chronic illnesses and require medical intervention.
  • Additional trends and insights available with purchase
Pharmaceutical Preparations Manufacturing in Ireland
Revenue (2014-2029)
IBISWorld Logo Source: IBISWorld

Industry outlook (2024-2029)

Market size is projected to grow over the next five years.

Trends and Insights

New technology and economies of scale will reduce manufacturing costs, benefitting profit

  • In Budget 2024, the government temporarily halted funding for new medicines in Ireland, which it had previously funded since 2021. The decision is set to be reversed in 2025, with € 30 million earmarked for medicine innovation.

Biggest companies in the Pharmaceutical Preparations Manufacturing in Ireland

Company
Market Share (%)
2023
Revenue (€m)
2023
Janssen Sciences Ireland Unlimited Company
6,480.1
Pfizer Healthcare Ireland
4,354.0
Merck Sharp & Dohme Ireland (Human Health) Limited
2,322.9

To view the market share and analysis for all 3 top companies in this industry, view purchase options.

Products & Services Segmentation

Pharmaceutical Preparations Manufacturing in Ireland
Products & Services
IBISWorld Logo Source: IBISWorld

Industry revenue is measured across several distinct product and services lines, including Therapeutic or prophylactic medication, Vaccines and antibiotics and Biopharmaceuticals. Therapeutic or prophylactic medication is the largest segment of the Pharmaceutical Preparations Manufacturing in Ireland.

Trends and Insights

The ageing population has kept revenue steady from therapeutic or prophylactic medication

  • This segment incorporates all medicines designed to cure a disease or relieve pain and medications designed to protect from or prevent illness, ranging from prescription pharmaceuticals to over-the-counter drugs.
  • More insights available in the full report

Table of Contents

About this industry

Industry definition

This industry includes companies that manufacture medications, chemical contraceptive products, medical diagnostic preparations, radioactive in-vivo diagnostic substances, animal health products and biotech pharmaceuticals. It also includes those that manufacture medical impregnated wadding, gauze, bandages and dressings, and that prepare botanical products for pharmaceutical use.

What's included in this industry?

Therapeutic or prophylactic medicationVaccines and antibioticsBiopharmaceuticalsMedicaments containing hormones or steroidsChemical contraceptive medicationsAnimal health products

Companies

Janssen Sciences Ireland Unlimited CompanyPfizer Healthcare IrelandMerck Sharp & Dohme Ireland (Human Health) Limited

Purchase this report to view all 3 major companies in this industry.

Related Terms

BLOCKBUSTER PRODUCTSGENERIC DRUGS HEATH SERVICE EXECUTIVE (HSE) PRIMARY CARE REIMBURSEMENT SERVICE

Industry Code

SIC 2007

SIC 21.20 - Pharmaceutical Preparations Manufacturing in Ireland

Performance

Get an indication of the industry's health through historical, current and forward-looking trends in the performance indicators that make or break businesses.

Analyst insights

Rising prevalence of chronic illnesses. As people get older, they are more likely to develop chronic illnesses and require medical intervention. The rising prevalence of diab...

In this chapter (4)

  • Current Performance
  • Outlook
  • Volatility
  • Life Cycle

Key metrics

  • Annual Revenue, Recent Growth, Forecast, Revenue Volatility
  • Number of Employees, Recent Growth, Forecast, Employees per Business, Revenue per Employee
  • Number of Businesses, Recent Growth, Forecast, Employees per Business, Revenue per Business
  • Total Profit, Profit Margin, Profit per Business

Charts

  • Revenue, including historical (2014-2023) and forecast (2024-2029)
  • Employees, including historical (2014-2023) and forecast (2024-2029)
  • Businesses, including historical (2014-2023) and forecast (2024-2029)
  • Profit, including historical (2014-2024)
  • Industry Volatility vs. Revenue Growth
  • Industry Life Cycle

Detailed analysis

  • Trends in supply, demand and current events that are driving current industry performance
  • Expected trends, economic factors and ongoing events that drive the industry's outlook
  • Key success factors for businesses to overcome volatility
  • How contribution to GDP, industry saturation, innovation, consolidation, and technology and systems influence the industry's life cycle phase.

Products and Markets

Learn about an industry's products and services, markets and trends in international trade.

Analyst insight

Demand for therapeutic and prophylactic medication is growing. This segment's share of revenue has remained fairly stable over the past few years, as the effects of growing d...

In this chapter

  • Products & Services
  • Major Markets
  • International Trade

Key metrics

  • Largest market segment and value in 2024
  • Product innovation level
  • Total imports, level and trend
  • Total exports, level and trend
  • Trade Balance

Charts

  • Products & services segmentation in 2024
  • Major market segmentation in 2024
  • International trade, including imports by country and exports by country

Detailed analysis

  • Trends impacting the recent performance of the industry's various segments
  • Innovations in the industry's product or service offering, specialization or delivery method
  • Key factors that successful businesses consider in their offerings
  • Buying segments and key trends influencing demand for industry products and services
  • Recent trends in import and export volumes, country of origin or destination, and expected future trends

Geographic Breakdown

Discover where business activity is most concentrated in an industry and the factors driving these trends to find opportunities and conduct regional benchmarking.

Analyst insights

Dublin accounts for a high number of pharmaceutical manufacturing establishments. A large number of pharmaceutical companies have their headquarters in the capital, where the...

In this chapter (1)

  • Business Locations

Charts

  • Share of revenue, establishment, wages and employment in each region
  • Share of population compared to establishments in each region in 2024

Tables

  • Number and share of establishments in each region in 2024
  • Number and share of revenue each region accounts for in 2024
  • Number and share of wages each region accounts for in 2024
  • Number and share of employees in each region in 2024

Detailed analysis

  • Geographic spread of the industry across Europe, and trends associated with changes in the business landscape
  • Key success factors for businesses to use location to their advantage

Competitive Forces

Get data and insights on what's driving competition in an industry and the challenges industry operators and new entrants may face, with analysis built around Porter's Five Forces framework.

Analyst insights

For non-patented products, manufacturers compete heavily on price. However, some manufacturers can use reputational advantages due to the importance consumers place on produc...

In this chapter (4)

  • Concentration
  • Barriers to Entry
  • Substitutes
  • Buyer & Supplier Analysis

Key metrics

  • Industry concentration level
  • Industry competition level and trend
  • Barriers to entry level and trend
  • Substitutes level and trend
  • Buyer power level and trend
  • Supplier power level and trend

Charts

  • Market share concentration among the top 4 suppliers from 2019-2024
  • Supply chain including upstream supplying industries and downstream buying industries, flow chart

Detailed analysis

  • Factors impacting the industry’s level of concentration, such as business distribution, new entrants, or merger and acquisition activity.
  • Key success factors for businesses to manage the competitive environment of the industry.
  • Challenges that potential industry entrants face such as legal, start-up costs, differentiation, labor/capital intensity and capital expenses.
  • Key success factors for potential entrants to overcome barriers to entry.
  • Competitive threats from potential substitutes for the industry’s own products and services.
  • Key success factors for how successful businesses can compete with substitutes.
  • Advantages that buyers have to keep favorable purchasing conditions.
  • Advantages that suppliers have to maintain favorable selling conditions.
  • Key success factors for how businesses can navigate buyer and supplier power.

Companies

Learn about the performance of the top companies in the industry.

Analyst insights

The industry is highly fragmented. It is characterised by major global players operating alongside small-scale biotech, botanical and homoeopathic product manufacturers. The ...

In this chapter

  • Market Share Concentration
  • Companies
  • Company Spotlights

Charts

  • Industry market share by company in 2020 through 2024
  • Major companies in the industry, including market share, revenue, profit and profit margin in 2024
  • Overview of Janssen Sciences Ireland Unlimited Company's performance by revenue, market share and profit margin from 2018 through 2024
  • Overview of Pfizer Healthcare Ireland's performance by revenue, market share and profit margin from 2018 through 2024
  • Overview of Merck Sharp & Dohme Ireland (Human Health) Limited's performance by revenue, market share and profit margin from 2018 through 2024

Detailed analysis

  • Description and key data for Janssen Sciences Ireland Unlimited Company, and factors influencing its performance in the industry
  • Description and key data for Pfizer Healthcare Ireland, and factors influencing its performance in the industry
  • Description and key data for Merck Sharp & Dohme Ireland (Human Health) Limited, and factors influencing its performance in the industry

External Environment

Understand the demographic, economic and regulatory factors that shape how businesses in an industry perform.   

Analyst insights

The euro to dollar exchange rate is falling. This provides pharmaceutical manufacturers an opportunity as revenue depends on international trade. A weak euro makes imports mo...

In this chapter

  • External Drivers
  • Regulation & Policy
  • Assistance

Key metrics

  • Regulation & policy level and trend
  • Assistance level and trend

Charts

  • Regulation & Policy historical data and forecast (2014-2029) 
  • Assistance historical data and forecast (2014-2029) 

Detailed analysis

  • Demographic and macroeconomic factors influencing the industry, including Regulation & Policy and Assistance
  • Major types of regulations, regulatory bodies, industry standards or specific regulations impacting requirements for industry operators
  • Key governmental and non-governmental groups or policies that may provide some relief for industry operators.

Financial Benchmarks

View average costs for industry operators and compare financial data against an industry's financial benchmarks over time. 

Analyst insights

Profit varies considerably among pharmaceutical manufacturers. This is based on enterprise size, the type of products sold, the quantity produced and contract agreements with...

In this chapter

  • Cost Structure
  • Financial Ratios
  • Key Ratios

Key metrics

  • Profit margin, and how it compares to the sector-wide margin
  • Average wages, and how it compares to the sector-wide average wage
  • Largest cost component as a percentage of revenue
  • Industry average ratios for days' receivables, industry coverage and debt-to-net-worth ratio

Charts

  • Average industry operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
  • Average sector operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
  • Investment vs. share of economy

Data tables

  • Cash Flow & Debt Service Ratios (2014-2029)
  • Revenue per Employee (2014-2029)
  • Revenue per Enterprise (2014-2029)
  • Employees per Establishment (2014-2029)
  • Employees per Enterprise (2014-2029)
  • Average Wage (2014-2029)
  • Wages/Revenue (2014-2029)
  • Establishments per Enterprise (2014-2029)
  • IVA/Revenue (2014-2029)
  • Imports/Demand (2014-2029)
  • Exports/Revenue (2014-2029)

Detailed analysis

  • Trends in the cost component for industry operators and their impact on industry costs and profitability 

Key Statistics

Industry Data

Data Tables

Including values and annual change:

  • Revenue (2014-2029)
  • IVA (2014-2029)
  • Establishments (2014-2029)
  • Enterprises (2014-2029)
  • Employment (2014-2029)
  • Exports (2014-2029)
  • Imports (2014-2029)
  • Wages (2014-2029)

Top Questions Answered

Unlock comprehensive answers and precise data upon purchase. View purchase options.

What is the market size of the Pharmaceutical Preparations Manufacturing industry in Ireland in 2024?

The market size of the Pharmaceutical Preparations Manufacturing industry in Ireland is €66.2bn in 2024.

How many businesses are there in the Pharmaceutical Preparations Manufacturing in Ireland industry in 2024?

There are 124 businesses in the Pharmaceutical Preparations Manufacturing industry in Ireland, which has grown at a CAGR of 4.2 % between 2019 and 2024.

Has the Pharmaceutical Preparations Manufacturing industry in Ireland grown or declined over the past 5 years?

The market size of the Pharmaceutical Preparations Manufacturing industry in Ireland has been growing at a CAGR of 3.8 % between 2019 and 2024.

What is the forecast growth of the Pharmaceutical Preparations Manufacturing industry in Ireland over the next 5 years?

Over the next five years, the Pharmaceutical Preparations Manufacturing industry in Ireland is expected to grow.

What are the biggest companies in the Pharmaceutical Preparations Manufacturing market in Ireland?

The biggest companies operating in the Pharmaceutical Preparations Manufacturing market in Ireland are Janssen Sciences Ireland Unlimited Company, Pfizer Healthcare Ireland and Merck Sharp & Dohme Ireland (Human Health) Limited

What does the Pharmaceutical Preparations Manufacturing in Ireland include?

Therapeutic or prophylactic medication and Vaccines and antibiotics are part of the Pharmaceutical Preparations Manufacturing industry.

Which companies have the highest market share in the Pharmaceutical Preparations Manufacturing in Ireland?

The company holding the most market share in Ireland is Janssen Sciences Ireland Unlimited Company.

How competitive is the Pharmaceutical Preparations Manufacturing industry in Ireland?

The level of competition is high and steady in the Pharmaceutical Preparations Manufacturing industry in Ireland.

Related Industries

Widen your competitive advantage with related industries

Competitors

  • Medical & Dental Instrument Manufacturing in Ireland

Complementors

  • Basic Pharmaceutical Product Manufacturing in Ireland
  • Pharmaceutical Wholesaling in Ireland
  • Dispensing Chemists in Ireland

International industries

  • Global Pharmaceuticals & Medicine Manufacturing
  • Brand Name Pharmaceutical Manufacturing in the US
  • Generic Pharmaceutical Manufacturing in the US
  • Cell Therapy in the US
  • Drug & Alcohol Test Kit Manufacturing in the US

View all industries in Ireland

Methodology

How are IBISWorld reports created?

IBISWorld has been a leading provider of trusted industry research for over 50 years to the most successful companies worldwide. With offices in Australia, the United States, the United Kingdom, Germany and China, we are proud to have local teams of analysts that conduct research, data analysis and forecasting to produce data-driven industry reports.

Our analysts start with official, verified and publicly available sources of data to build the most accurate picture of each industry. Analysts then leverage their expertise and knowledge of the local markets to synthesize trends into digestible content for IBISWorld readers. Finally, each report is reviewed by one of IBISWorld’s editors, who provide quality assurance to ensure accuracy and readability.

IBISWorld relies on human-verified data and human-written analysis to compile each standard industry report. We do not use generative AI tools to write insights, although members can choose to leverage AI-based tools within the platform to generate additional analysis formats.

What data sources do IBISWorld analysts use?

Each industry report incorporates data and research from government databases, industry-specific sources, industry contacts, and our own proprietary database of statistics and analysis to provide balanced, independent and accurate insights.

Key data sources in Ireland include:

  • Central Statistics Office
  • Department of Enterprise, Trade and Employment
  • Irish Tax & Customs

Analysts also use industry specific sources to complement catch-all sources, although their perspective may focus on a particular organization or representative body, rather than a clear overview of all industry operations. However, when balanced against other perspectives, industry-specific sources provide insights into industry trends.

These sources include:

  • Industry and trade associations
  • Industry federations or regulators
  • Major industry players annual or quarterly filings

Finally, IBISWorld’s global data scientists maintain a proprietary database of macroeconomic and demand drivers, which our analysts use to help inform industry data and trends. They also maintain a database of statistics and analysis on thousands of industries, which has been built over our more than 50-year history and offers comprehensive insights into long-term trends.

How does IBISWorld forecast its data?

IBISWorld’s analysts and data scientists use the sources above to create forecasts for our proprietary datasets and industry statistics. Depending on the dataset, they may use regression analysis, multivariate analysis, time-series analysis or exponential smoothing techniques to project future data for the industry or driver. Additionally, analysts will leverage their local knowledge of industry operating and regulatory conditions to impart their best judgment on the forecast model.

IBISWorld prides itself on being a trusted, independent source of data, with over 50 years of experience building and maintaining rich datasets and forecasting tools. We are proud to be the keystone source of industry information for thousands of companies across the world.

Learn more about our methodology and data sourcing on the Help Center.